Tags

Type your tag names separated by a space and hit enter

[Implantation metastasis at the exit site after percutaneous endoscopic gastrostomy in esophageal carcinoma].
Z Gastroenterol. 1999 Sep; 37(9):789-93.ZG

Abstract

In patients with esophageal cancer causing obstruction percutaneous endoscopic gastrostomy (PEG) is a well-established procedure with a low complication rate to provide sufficient enteral nutrition. We report on a 68-year-old patient suffering from inoperable squamous cell cancer of the proximal esophagus, who underwent PEG insertion prior to a combined radiochemotherapy. Initially bougienage was performed because of subtotal esophageal stenosis. Four months later a metastasis was found at the PEG exit site with involvement of the gastric wall, most likely caused by spread of tumor cells during insertion of the PEG.

Authors+Show Affiliations

Deinzer M
Abteilung für Strahlentherapie, Radiologische Universitätsklinik, Universitätskliniken des Saarlandes, Homburg/Saar.
Menges M
No affiliation info available
Walter K
No affiliation info available
Püschel W
No affiliation info available
Braun A
No affiliation info available
Niewald M
No affiliation info available
Motaref B
No affiliation info available
Schnabel K
No affiliation info available

MeSH

AgedCarcinoma, Squamous CellEnteral NutritionEsophageal NeoplasmsFollow-Up StudiesGastrostomyHumansMaleNeoplasm SeedingPalliative CareSkin NeoplasmsStomach Neoplasms

Pub Type(s)

Case Reports
English Abstract
Journal Article
Review

Language

ger

PubMed ID

10522365

Citation

Deinzer, M, et al. "[Implantation Metastasis at the Exit Site After Percutaneous Endoscopic Gastrostomy in Esophageal Carcinoma]." Zeitschrift Fur Gastroenterologie, vol. 37, no. 9, 1999, pp. 789-93.
Deinzer M, Menges M, Walter K, et al. [Implantation metastasis at the exit site after percutaneous endoscopic gastrostomy in esophageal carcinoma]. Z Gastroenterol. 1999;37(9):789-93.
Deinzer, M., Menges, M., Walter, K., Püschel, W., Braun, A., Niewald, M., Motaref, B., & Schnabel, K. (1999). [Implantation metastasis at the exit site after percutaneous endoscopic gastrostomy in esophageal carcinoma]. Zeitschrift Fur Gastroenterologie, 37(9), 789-93.
Deinzer M, et al. [Implantation Metastasis at the Exit Site After Percutaneous Endoscopic Gastrostomy in Esophageal Carcinoma]. Z Gastroenterol. 1999;37(9):789-93. PubMed PMID: 10522365.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Implantation metastasis at the exit site after percutaneous endoscopic gastrostomy in esophageal carcinoma]. AU - Deinzer,M, AU - Menges,M, AU - Walter,K, AU - Püschel,W, AU - Braun,A, AU - Niewald,M, AU - Motaref,B, AU - Schnabel,K, PY - 1999/10/16/pubmed PY - 1999/10/16/medline PY - 1999/10/16/entrez SP - 789 EP - 93 JF - Zeitschrift fur Gastroenterologie JO - Z Gastroenterol VL - 37 IS - 9 N2 - In patients with esophageal cancer causing obstruction percutaneous endoscopic gastrostomy (PEG) is a well-established procedure with a low complication rate to provide sufficient enteral nutrition. We report on a 68-year-old patient suffering from inoperable squamous cell cancer of the proximal esophagus, who underwent PEG insertion prior to a combined radiochemotherapy. Initially bougienage was performed because of subtotal esophageal stenosis. Four months later a metastasis was found at the PEG exit site with involvement of the gastric wall, most likely caused by spread of tumor cells during insertion of the PEG. SN - 0044-2771 UR - https://www.unboundmedicine.com/medline/citation/10522365/[Implantation_metastasis_at_the_exit_site_after_percutaneous_endoscopic_gastrostomy_in_esophageal_carcinoma]_ L2 - https://medlineplus.gov/esophagealcancer.html DB - PRIME DP - Unbound Medicine ER -